ADAM10 as a Therapeutic Target for Cancer and Inflammation
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
2288-2299
Author(s):
Howard C. Crawford, Peter J. Dempsey, Gordon Brown, Liana Adam and Marcia L. Moss
The Therapeutic Potential of ADAM15
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
2311-2318
Author(s):
Neali Lucas, Abdo J. Najy and Mark L. Day
ADAM19/Adamalysin 19 Structure, Function, and Role as a Putative Target in Tumors and Inflammatory Diseases
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
2336-2348
Author(s):
Bin Qi, Robert G. Newcomer and Qing-Xiang Amy Sang
Semaphorins at the Interface of Development and Cancer
Journal:
Current Drug Targets
Volume:
10
Page:
611-619
Author(s):
E. Flannery and M. Duman-Scheel
Post-Wortmannin Era: Novel Phosphoinositide 3-Kinase Inhibitors with Potential Therapeutic Applications
Journal:
Current Enzyme Inhibition
Volume:
5
Page:
66-86
Author(s):
Laura Braccini, Fulvio Morello, Alessia Perino and Emilio Hirsch
Poly(ADP-Ribosylation): Beneficial Effects of Its Inhibition
Journal:
Current Enzyme Inhibition
Volume:
5
Page:
99-109
Author(s):
V. Giansanti, F. Dona and A. I. Scovassi
Peptides Targeting Angiogenesis Related Growth Factor Receptors
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
2414-2429
Author(s):
Luca D. D'Andrea, Annarita Del Gatto, Lucia De Rosa, Alessandra Romanelli and Carlo Pedone
Current Status and Perspectives in Peptide Receptor Radiation Therapy
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
2453-2462
Author(s):
Catherine Ansquer, Francoise Kraeber-Bodere and Jean Francoise Chatal
Peptides as Signaling Inhibitors for Mammalian MAP Kinase Cascades
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
2471-2480
Author(s):
Matthias Gaestel and Michael Kracht
Targeting Rho GTPases by Peptidic Structures
Journal:
Current Pharmaceutical Design
Volume:
15
Page:
2481-2487
Author(s):
Filippo Marchioni and Yi Zheng